Theratechnologies Inc. (OTCMKTS:THERF) announced its quarterly earnings results on Thursday. The company reported ($0.03) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.02) by ($0.01), MarketWatch Earnings reports. Theratechnologies had a negative return on equity of 29.87% and a negative net margin of 26.49%.

Theratechnologies (THERF) traded down 1.6690% during midday trading on Thursday, hitting $6.2098. The stock had a trading volume of 48,463 shares. The stock’s 50-day moving average is $6.07 and its 200-day moving average is $5.53. The company’s market cap is $462.10 million. Theratechnologies has a one year low of $1.95 and a one year high of $7.10.

WARNING: This piece was first published by American Banking News and is the property of of American Banking News. If you are accessing this piece on another site, it was copied illegally and republished in violation of US and international trademark & copyright laws. The correct version of this piece can be accessed at https://www.americanbankingnews.com/2017/10/05/theratechnologies-inc-therf-posts-earnings-results-misses-expectations-by-0-01-eps.html.

About Theratechnologies

Theratechnologies Inc, specialty pharmaceutical company, addresses unmet medical needs to promote healthy living and an enhanced life among HIV patients. Its lead product is EGRIFTA, which increases the incidence or progression of diabetic retinopathy in diabetic HIV-infected patients with lipodystrophy and excess abdominal fat in the United States and Canada.

Receive News & Ratings for Theratechnologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Theratechnologies Inc. and related companies with MarketBeat.com's FREE daily email newsletter.